75
Views
49
CrossRef citations to date
0
Altmetric
Review

Antiangiogenic therapy in brain tumors

&
Pages 1457-1473 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xing-qi Li, Zhi-gang Ouyang, Sheng-hua Zhang, Hong Liu, Yue Shang, Yi Li & Yong-su Zhen. (2014) Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin. Cancer Biology & Therapy 15:4, pages 398-408.
Read now
Marc C Chamberlain. (2008) Antiangiogenesis: biology and utility in the treatment of gliomas. Expert Review of Neurotherapeutics 8:10, pages 1419-1423.
Read now

Articles from other publishers (47)

Chiara Cencioni, Fiorella Scagnoli, Francesco Spallotta, Sergio Nasi & Barbara Illi. (2023) The “Superoncogene” Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme. International Journal of Molecular Sciences 24:4, pages 4217.
Crossref
Anni S. Halkola, Tero Aittokallio & Kalle Parvinen. (2022) Tumor microenvironment as a metapopulation model: The effects of angiogenesis, emigration and treatment modalities. Journal of Theoretical Biology 545, pages 111147.
Crossref
Mohammad Algahtani, Umamaheswari Natarajan, Khalid Alhazzani, Ali Alaseem & Appu Rathinavelu. (2022) Evaluation of anti-angiogenic agent F16 for targeting glioblastoma xenograft tumors. Cancer Genetics 264-265, pages 71-89.
Crossref
Li Li, Jianhong Chen, Yue Ming, Bin Li, Ruoqiu Fu, Dongyu Duan, Ziwei Li, Rui Ni, Xianfeng Wang, Yueling Zhou & Lin Zhang. (2022) The Application of Peptides in Glioma: A Novel Tool for Therapy. Current Pharmaceutical Biotechnology 23:5, pages 620-633.
Crossref
Ebrahim Balandeh, Kimia Mohammadshafie, Yaser Mahmoudi, Mohammad Hossein Pourhanifeh, Ali Rajabi, Zahra Razaghi Bahabadi, Amir Hossein Mohammadi, Neda Rahimian, Michael R. Hamblin & Hamed Mirzaei. (2021) Roles of Non-coding RNAs and Angiogenesis in Glioblastoma. Frontiers in Cell and Developmental Biology 9.
Crossref
Vinitha Rani & Ashwini Prabhu. (2021) Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment. Current Pharmaceutical Design 27:7, pages 919-931.
Crossref
Maruf M. Hoque, Hanaa Abdelazim, Clifton Jenkins‐Houk, Dawn Wright, Biraj M. Patel & John C. Chappell. (2020) The cerebral microvasculature: Basic and clinical perspectives on stroke and glioma. Microcirculation 28:3.
Crossref
Joris Guyon, Candice Chapouly, Laetitia Andrique, Andreas Bikfalvi & Thomas Daubon. (2021) The Normal and Brain Tumor Vasculature: Morphological and Functional Characteristics and Therapeutic Targeting. Frontiers in Physiology 12.
Crossref
Pariya Khalili, Sareh Zolatash, Ramin Vatankhah & Sajjad Taghvaei. (2021) Optimal control methods for drug delivery in cancerous tumour by anti‐angiogenic therapy and chemotherapy. IET Systems Biology 15:1, pages 14-25.
Crossref
Indu Sharma & Satabdi Bhattacharjee. 2021. Nanobiotechnology. Nanobiotechnology 51 60 .
Francesca Petralia, Nicole Tignor, Boris Reva, Mateusz Koptyra, Shrabanti Chowdhury, Dmitry Rykunov, Azra Krek, Weiping Ma, Yuankun Zhu, Jiayi Ji, Anna Calinawan, Jeffrey R. Whiteaker, Antonio Colaprico, Vasileios Stathias, Tatiana Omelchenko, Xiaoyu Song, Pichai Raman, Yiran Guo, Miguel A. Brown, Richard G. Ivey, John Szpyt, Sanjukta Guha Thakurta, Marina A. Gritsenko, Karl K. Weitz, Gonzalo Lopez, Selim Kalayci, Zeynep H. Gümüş, Seungyeul Yoo, Felipe da Veiga Leprevost, Hui-Yin Chang, Karsten Krug, Lizabeth Katsnelson, Ying Wang, Jacob J. Kennedy, Uliana J. Voytovich, Lei Zhao, Krutika S. Gaonkar, Brian M. Ennis, Bo Zhang, Valerie Baubet, Lamiya Tauhid, Jena V. Lilly, Jennifer L. Mason, Bailey Farrow, Nathan Young, Sarah Leary, Jamie Moon, Vladislav A. Petyuk, Javad Nazarian, Nithin D. Adappa, James N. Palmer, Robert M. Lober, Samuel Rivero-Hinojosa, Liang-Bo Wang, Joshua M. Wang, Matilda Broberg, Rosalie K. Chu, Ronald J. Moore, Matthew E. Monroe, Rui Zhao, Richard D. Smith, Jun Zhu, Ana I. Robles, Mehdi Mesri, Emily Boja, Tara Hiltke, Henry Rodriguez, Bing Zhang, Eric E. Schadt, D.R. Mani, Li Ding, Antonio Iavarone, Maciej Wiznerowicz, Stephan Schürer, Xi S. Chen, Allison P. Heath, Jo Lynne Rokita, Alexey I. Nesvizhskii, David Fenyö, Karin D. Rodland, Tao Liu, Steven P. Gygi, Amanda G. Paulovich, Adam C. Resnick, Phillip B. Storm, Brian R. Rood, Pei Wang, Alicia Francis, Allison M. Morgan, Angela J. Waanders, Angela N. Viaene, Anna Maria Buccoliero, Arul M. Chinnaiyan, Carina A. Leonard, Cassie N. Kline, Chiara Caporalini, Christopher R. Kinsinger, Chunde Li, David E. Kram, Derek Hanson, Elizabeth Appert, Emily A. Kawaler, Eric H. Raabe, Eric M. Jackson, Jeffrey P. Greenfield, Gabrielle S. Stone, Gad Getz, Gerald Grant, Guo Ci Teo, Ian F. Pollack, Jason E. Cain, Jessica B. Foster, Joanna J. Phillips, July E. Palma, Karen A. Ketchum, Kelly V. Ruggles, Lili Blumenberg, Macintosh Cornwell, Mahdi Sarmady, Marcin J. Domagalski, Marcin P. Cieślik, Mariarita Santi, Marilyn M. Li, Matthew J. Ellis, Matthew A. Wyczalkowski, Meghan Connors, Mirko Scagnet, Nalin Gupta, Nathan J. Edwards, Nicholas A. Vitanza, Olena M. Vaske, Oren Becher, Peter B. McGarvey, Ron Firestein, Sabine Mueller, Samuel G. Winebrake, Saravana Mohan Dhanasekaran, Shuang Cai, Sonia Partap, Tatiana Patton, Toan Le, Travis D. Lorentzen, Wenke Liu & William E. Bocik. (2020) Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer. Cell 183:7, pages 1962-1985.e31.
Crossref
Yulei Chen, Longbin Guo, Xuanzi Li, Rongping Liu, Chen Ren & Shasha Du. (2020) Reduced-dose bevacizumab vs. standard-dose bevacizumab in recurrent high-grade glioma: Which one is better? A meta-analysis. Clinical Neurology and Neurosurgery 198, pages 106239.
Crossref
Vishal Chavda, Vimal Patel, Dhananjay Yadav, Jigar Shah, Snehal Patel & Jun-O Jin. (2020) Therapeutics and Research Related to Glioblastoma: Advancements and Future Targets. Current Drug Metabolism 21:3, pages 186-198.
Crossref
Bhavesh K. Ahir, Herbert H. Engelhard & Sajani S. Lakka. (2020) Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma. Molecular Neurobiology 57:5, pages 2461-2478.
Crossref
Michele d'Angelo, Vanessa Castelli, Elisabetta Benedetti, Andrea Antonosante, Mariano Catanesi, Reyes Dominguez-Benot, Giuseppina Pitari, Rodolfo Ippoliti & Annamaria Cimini. (2019) Theranostic Nanomedicine for Malignant Gliomas. Frontiers in Bioengineering and Biotechnology 7.
Crossref
KA Mander & JW Finnie. (2018) Tumour angiogenesis, anti-angiogenic therapy and chemotherapeutic resistance. Australian Veterinary Journal 96:10, pages 371-378.
Crossref
Loubna Abdel Hadi, Viviana Anelli, Laura Guarnaccia, Stefania Navone, Matteo Beretta, Francesco Moccia, Cristina Tringali, Vasile Urechie, Rolando Campanella, Giovanni Marfia & Laura Riboni. (2018) A bidirectional crosstalk between glioblastoma and brain endothelial cells potentiates the angiogenic and proliferative signaling of sphingosine-1-phosphate in the glioblastoma microenvironment. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1863:10, pages 1179-1192.
Crossref
Sylvie Lamy, Évelyne Muhire & Borhane Annabi. (2018) Antiproliferative efficacy of elderberries and elderflowers (Sambucus canadensis) on glioma and brain endothelial cells under normoxic and hypoxic conditions. Journal of Functional Foods 40, pages 164-179.
Crossref
Vera Miranda-Gonçalves, Filipa Bezerra, Raquel Costa-Almeida, Marta Freitas-Cunha, Raquel Soares, Olga Martinho, Rui M. Reis, Céline Pinheiro & Fátima Baltazar. (2017) Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk. Molecular Carcinogenesis 56:12, pages 2630-2642.
Crossref
Yung-Chih Kuo, Chia-Hao Lee & Rajendiran Rajesh. (2017) Recent advances in the treatment of glioblastoma multiforme by inhibiting angiogenesis and using nanocarrier systems. Journal of the Taiwan Institute of Chemical Engineers 77, pages 30-40.
Crossref
. 2017. Engineering 3D Tissue Test Systems. Engineering 3D Tissue Test Systems 377 400 .
Y Rajesh, Ipsita Pal, Payel Banik, Sandipan Chakraborty, Sachin A Borkar, Goutam Dey, Ahona Mukherjee & Mahitosh Mandal. (2017) Insights into molecular therapy of glioma: current challenges and next generation blueprint. Acta Pharmacologica Sinica 38:5, pages 591-613.
Crossref
Caixing Sun, Yang Yu, Lizhen Wang, Bin Wu, Liang Xia, Fang Feng, Zhiqiang Ling & Shihua Wang. (2016) Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Wonyoung Kang, Sung Heon Kim, Hee Jin Cho, Juyoun Jin, Jeongwu Lee, Kyeung Min Joo & Do-Hyun Nam. (2015) Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme. Oncotarget 6:29, pages 27239-27251.
Crossref
Patrick M. Flanigan & Manish K. Aghi. (2015) Adaptation to antiangiogenic therapy in neurological tumors. Cellular and Molecular Life Sciences 72:16, pages 3069-3082.
Crossref
Meng‐Yin Yang, Ming‐Tsang Chiao, Hsu‐Tung Lee, Chien‐Min Chen, Yi‐Chin Yang, Chiung‐Chyi Shen & Hsin‐I. Ma. (2014) An innovative three‐dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior. Journal of Biomedical Materials Research Part B: Applied Biomaterials 103:3, pages 618-628.
Crossref
Hu Zhu, Richard L. Carpenter, Woody Han & Hui-Wen Lo. (2014) The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth. Cancer Letters 343:1, pages 51-61.
Crossref
Michelle Visagie, Anne Theron, Thandi Mqoco, Warren Vieira, Renaud Prudent, Anne Martinez, Laurence Lafanechère & Annie Joubert. (2013) Sulphamoylated 2-Methoxyestradiol Analogues Induce Apoptosis in Adenocarcinoma Cell Lines. PLoS ONE 8:9, pages e71935.
Crossref
Huan Yu, Lirong Teng, Qingfan Meng, Yuhuan Li, Xiaocheng Sun, Jiahui Lu, Robert J. Lee & Lesheng Teng. (2013) Development of liposomal Ginsenoside Rg3: Formulation optimization and evaluation of its anticancer effects. International Journal of Pharmaceutics 450:1-2, pages 250-258.
Crossref
S.T.R. Pinho, F.S. Bacelar, R.F.S. Andrade & H.I. Freedman. (2013) A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy. Nonlinear Analysis: Real World Applications 14:1, pages 815-828.
Crossref
Qin Ru, Bo-yang Shang, Qing-fang Miao, Liang Li, Shu-ying Wu, Rui-juan Gao & Yong-su Zhen. (2012) A cell penetrating peptide-integrated and enediyne-energized fusion protein shows potent antitumor activity. European Journal of Pharmaceutical Sciences 47:4, pages 781-789.
Crossref
Thomas N. Seyfried, Jeremy Marsh, Laura M. Shelton, Leanne C. Huysentruyt & Purna Mukherjee. (2012) Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?. Epilepsy Research 100:3, pages 310-326.
Crossref
Thomas N. Seyfried. 2012. Cancer as a Metabolic Disease. Cancer as a Metabolic Disease 291 354 .
Ivan Urits, Purna Mukherjee, Joshua Meidenbauer & Thomas N. Seyfried. (2012) Dietary Restriction Promotes Vessel Maturation in a Mouse Astrocytoma. Journal of Oncology 2012, pages 1-10.
Crossref
M. H. Visagie & A. M. Joubert. (2011) 2-Methoxyestradiol-bis-sulfamate induces apoptosis and autophagy in a tumorigenic breast epithelial cell line. Molecular and Cellular Biochemistry 357:1-2, pages 343-352.
Crossref
Leanne C HuysentruytZeynep AkgocThomas N Seyfried. (2011) Hypothesis: Are Neoplastic Macrophages/Microglia Present in Glioblastoma Multiforme?. ASN Neuro 3:4, pages AN20110011.
Crossref
Thomas N. Seyfried, Michael A. Kiebish, Jeremy Marsh, Laura M. Shelton, Leanne C. Huysentruyt & Purna Mukherjee. (2011) Metabolic management of brain cancer. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1807:6, pages 577-594.
Crossref
Michelle H Visagie & Anna M Joubert. (2011) In vitro effects of 2-methoxyestradiol-bis-sulphamate on reactive oxygen species and possible apoptosis induction in a breast adenocarcinoma cell line. Cancer Cell International 11:1, pages 43.
Crossref
Steven Brem & Eric T. Wong. 2011. Youmans Neurological Surgery. Youmans Neurological Surgery 1151 1171 .
Walter J. Lukiw & Frank Culicchia. 2011. Neurochemical Mechanisms in Disease. Neurochemical Mechanisms in Disease 799 821 .
Antonio Di Ieva. (2010) Angioarchitectural morphometrics of brain tumors: Are there any potential histopathological biomarkers?. Microvascular Research 80:3, pages 522-533.
Crossref
Antonio Di Ieva, Fabio Grizzi, Manfred Tschabitscher, Piergiuseppe Colombo, Massimiliano Casali, Matteo Simonelli, Georg Widhalm, Pier Carlo Muzzio, Christian Matula, Arturo Chiti & Riccardo Rodriguez y Baena. (2010) Correlation of microvascular fractal dimension with positron emission tomography [11C]-methionine uptake in glioblastoma multiforme: Preliminary findings. Microvascular Research 80:2, pages 267-273.
Crossref
Laura M SheltonLeanne C HuysentruytPurna MukherjeeThomas N Seyfried. (2010) Calorie Restriction as an Anti-Invasive Therapy for Malignant Brain Cancer in the VM Mouse. ASN Neuro 2:3, pages AN20100002.
Crossref
Michelle Visagie & Annie Joubert. (2010) The in vitro effects of 2-methoxyestradiol-bis-sulphamate on cell numbers, membrane integrity and cell morphology, and the possible induction of apoptosis and autophagy in a non-tumorigenic breast epithelial cell line. Cellular and Molecular Biology Letters 15:4.
Crossref
Qing GeJohn J XuDavid M EvansA James Mixson, Harry Y YangPatrick Y Lu. (2009) Leveraging therapeutic potential of multi-targeted siRNA inhibitors. Future Medicinal Chemistry 1:9, pages 1671-1681.
Crossref
Tai-Guo Liu, Ying Huang, Dan-Dan Cui, Xiao-Bing Huang, Shu-Hua Mao, Ling-Ling Ji, Hai-Bo Song & Cheng Yi. (2009) Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 9:1.
Crossref
Juan JuanYin, Kirsten Tracy, Luhua Zhang, Jeeva Munasinghe, Erik Shapiro, Alan Koretsky & Kathleen Kelly. (2009) Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model. Clinical & Experimental Metastasis 26:5, pages 403-414.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.